Assignee profile
Wuhan Humanwell Innovative Drug Research And Development Center
Coverage of patents, compounds and activity records linked to this assignee.
1 patents4 compounds8 activity records
Summary
AssigneeWuhan Humanwell Innovative Drug Research And Development Center
Filing years2025
Patents1
Compounds4
Activity records8
Patent families1
Targets1
Assay familiesdegradation
Activity metricsDC50, Dmax
Overview
Target distribution and active-compound trend
Target distribution
8 activity records
Active compounds by publication year
Distinct compounds linked to assignee patent publications
Activity compounds and values
Activity records
| Structure | Control | Value | Concentration | Time | Record ID | Compound | Assay | Details | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Dmax | - | = | 98.1 | % | - | - | VAV1 | - | Jurkat | WO2026041143A1 | PGDB_A014016 | PGDB_C009245 | PGDB_AS000206 | View |
| DC50 | - | <= | 10 | nM | - | — | VAV1 | - | Jurkat | WO2026041143A1 | PGDB_A039440 | PGDB_C009245 | PGDB_AS001882 | View |
 | Dmax | - | = | 97 | % | - | - | VAV1 | - | Jurkat | WO2026041143A1 | PGDB_A040912 | PGDB_C009246 | PGDB_AS000206 | View |
 | DC50 | - | <= | 10 | nM | - | — | VAV1 | - | Jurkat | WO2026041143A1 | PGDB_A041053 | PGDB_C009248 | PGDB_AS001882 | View |
| Dmax | - | = | 96 | % | - | - | VAV1 | - | Jurkat | WO2026041143A1 | PGDB_A053339 | PGDB_C009248 | PGDB_AS000206 | View |
 | Dmax | - | = | 97.7 | % | - | - | VAV1 | - | Jurkat | WO2026041143A1 | PGDB_A056571 | PGDB_C009247 | PGDB_AS000206 | View |
| DC50 | - | <= | 10 | nM | - | — | VAV1 | - | Jurkat | WO2026041143A1 | PGDB_A061325 | PGDB_C009246 | PGDB_AS001882 | View |
| DC50 | - | <= | 10 | nM | - | — | VAV1 | - | Jurkat | WO2026041143A1 | PGDB_A077287 | PGDB_C009247 | PGDB_AS001882 | View |